Public Profile

Grifols

Grifols, officially known as Grifols, S.A., is a global leader in the biopharmaceutical industry, headquartered in Barcelona, Spain (ES). Founded in 1940, the company has established a strong presence in key operational regions, including Europe, North America, and Latin America. Grifols specialises in the development of plasma-derived medicines, diagnostic solutions, and hospital products, with a commitment to improving patient health. The company is renowned for its innovative therapies, particularly in the treatment of rare and chronic diseases, setting it apart in a competitive market. Grifols has achieved significant milestones, including the expansion of its plasma collection network and advancements in immunology. With a robust market position, Grifols continues to be recognised for its contributions to healthcare, making it a trusted name in the biopharmaceutical sector.

DitchCarbon Score

How does Grifols's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

54

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

23

Industry Benchmark

Grifols's score of 54 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.

97%

Let us know if this data was useful to you

Grifols's reported carbon emissions

In 2023, Grifols reported total emissions of approximately 106,459,000 kg CO2e from Scope 1 and 2 sources, with a significant portion attributed to stationary combustion and purchased electricity. The company has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2022 as the baseline year. Additionally, Grifols targets a 25% reduction in absolute Scope 3 emissions, which encompass emissions from purchased goods and services, capital goods, fuel- and energy-related activities, and upstream transportation and distribution, also by 2030. In 2020, Grifols's emissions included approximately 34,588,000 kg CO2e from Scope 1 and about 10,450,500 kg CO2e from Scope 2 in Spain alone. The company has demonstrated a commitment to sustainability by aligning its targets with the Science Based Targets initiative (SBTi), ensuring that its reduction goals are consistent with the global aim to limit warming to 1.5°C. Grifols's proactive approach to managing its carbon footprint reflects its dedication to environmental responsibility within the pharmaceutical and biotechnology sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201820192020202120222023
Scope 1
98,043,000
000,000,000
000,000,000
000,000,000
00,000,000
000,000,000
Scope 2
120,493,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
Scope 3
77,388,000
00,000,000
00,000,000
0,000,000,000
0,000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Grifols's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Grifols is in ES, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Grifols is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Sanofi Pasteur SA

FR
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Baxalta Incorporated

US
Health and social work services (85)
Updated 3 months ago
DitchCarbon Score

Biomerieux

FR
Chemicals nec
Updated 1 day ago

Beckman Coulter, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 6 days ago

Hologic

US
Research and development services (73)
Updated 1 day ago

BioMarin

US
Chemicals nec
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers